Senate
File
296
H-1350
Amend
Senate
File
296,
as
passed
by
the
Senate,
as
follows:
1
1.
By
striking
everything
after
the
enacting
clause
and
2
inserting:
3
<
Section
1.
Section
155A.46,
subsection
1,
paragraph
a,
4
Code
2021,
is
amended
by
adding
the
following
new
subparagraph:
5
NEW
SUBPARAGRAPH
.
(7)
An
immunization
or
vaccination
for
6
C0VID-19
as
defined
in
section
686D.2.
7
Sec.
2.
Section
155A.46,
subsection
1,
Code
2021,
is
amended
8
by
adding
the
following
new
paragraph:
9
NEW
PARAGRAPH
.
e.
A
pharmacist
may,
pursuant
to
statewide
10
protocols
developed
by
the
board
in
consultation
with
the
11
department
of
public
health
and
consistent
with
subsection
2,
12
order
and
administer
the
following
to
patients
ages
six
years
13
and
older:
14
(1)
Point-of-care
testing
and
treatment
for
influenza,
15
streptococcus
A,
and
COVID-19
as
defined
in
section
686D.2
at
16
the
point
of
interaction
between
a
pharmacist
and
a
patient.
17
(2)
Point-of-care
testing
at
the
point
of
interaction
18
between
a
pharmacist
and
a
patient
in
response
to
a
public
19
health
emergency.
20
Sec.
3.
NEW
SECTION
.
155A.47
Collaborative
pharmacy
21
practice
——
agreements
——
payment.
22
1.
For
the
purposes
of
this
section:
23
a.
“Collaborative
pharmacy
practice”
means
a
practice
of
24
pharmacy
whereby
a
pharmacist
provides
patient
care
and
drug
25
therapy
management
services
not
otherwise
permitted
to
be
26
performed
by
a
pharmacist
to
patients
under
a
collaborative
27
pharmacy
practice
agreement
with
another
pharmacist
or
28
practitioner
which
defines
the
nature,
scope,
conditions,
and
29
limitations
of
the
patient
care
and
drug
therapy
management
30
services
to
be
provided
by
a
pharmacist
in
order
to
ensure
that
31
a
patient
achieves
the
desired
outcomes.
32
b.
“Health
benefit
plan”
means
the
same
as
defined
in
33
section
514J.102.
34
c.
“Health
carrier”
means
the
same
as
defined
in
section
35
-1-
SF296.1802
(1)
89
ss/rh
1/
2
#1.
514J.102.
1
2.
Notwithstanding
any
provision
of
law
to
the
contrary,
a
2
pharmacist
may
engage
in
a
collaborative
pharmacy
practice,
in
3
accordance
with
rules
adopted
by
the
board
pursuant
to
chapter
4
17A
and
under
a
collaborative
pharmacy
practice
agreement,
to
5
provide
patient
care
and
drug
therapy
management
services
to
6
a
patient.
7
3.
Notwithstanding
any
provision
of
a
health
benefit
plan
8
to
the
contrary,
whenever
a
health
benefit
plan
provides
for
9
payment
or
reimbursement
for
a
service
that
is
within
the
10
lawful
scope
of
practice
of
a
practitioner
or
pharmacist
11
and
the
service
is
provided
by
a
pharmacist
pursuant
to
a
12
collaborative
pharmacy
practice
agreement
under
this
section,
13
the
health
carrier
may
provide
payment
or
reimbursement
for
the
14
service.
>
15
______________________________
A.
MEYER
of
Webster
-2-
SF296.1802
(1)
89
ss/rh
2/
2